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Background: In thermal ablation of liver tumors, complete coverage of the tumor volume
by the ablation volume with a sufficient ablation margin is the most important factor for
treatment success. Evaluation of ablation completeness is commonly performed by visual
inspection in 2D and is prone to inter-reader variability. This work aimed to introduce a
standardized approach for evaluation of ablation completeness after CT-guided thermal
ablation of liver tumors, using volumetric quantitative ablation margins (QAM).
Methods: A QAM computation metric based on volumetric segmentations of tumor and
ablation areas and signed Euclidean surface distance maps was developed, including a
novel algorithm to address QAM computation in subcapsular tumors. The code for QAM
computation was verified in artificial examples of tumor and ablation spheres simulating
varying scenarios of ablation margins. The applicability of the QAM metric was
investigated in representative cases extracted from a prospective database of
colorectal liver metastases (CRLM) treated with stereotactic microwave ablation (SMWA).
Results: Applicability of the proposed QAM metric was confirmed in artificial and clinical
example cases. Numerical and visual options of data presentation displaying substrata of
QAM distributions were proposed. For subcapsular tumors, the underestimation of tumor
coverage by the ablation volume when applying an unadjusted QAM method was
confirmed, supporting the benefits of using the proposed algorithm for QAM
computation in these cases. The computational code for developed QAM was made
publicly available, encouraging the use of a standard and objective metric in reporting
ablation completeness and margins.
Conclusion: The proposed volumetric approach for QAM computation including a novel
algorithm to address subcapsular liver tumors enables precision and reproducibility in the
assessment of ablation margins. The quantitative feedback on ablation completenessMarch 2021 | Volume 11 | Article 6230981
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predictability and consistency of local tumor control after thermal ablation of liver tumors.Keywords: liver neoplasms, ablation techniques, computer-assisted therapies, stereotactic techniques,
interventional radiologyINTRODUCTION
Image-guided thermal ablation using microwaves (MWA) or
radiofrequency (RFA) is an established tissue-sparing, low-
morbidity treatment techniques for malignant liver tumors (1).
Frequently applied imaging modalities include ultrasound,
computed tomography (CT), or magnetic resonance imaging
(MRI), which allow high quality guidance in a minimally
invasive treatment environment. To further increase targeting
accuracy, safety, and treatment reproducibility, stereotactic
navigation systems have been introduced and the results
reported in clinical studies (2–5).
Themost important factor defining treatment success in thermal
ablation is a complete coverage of the targeted tumor by the ablation
volume, with a sufficient ablation margin. The latter was confirmed
to be an independent predictor of ablation site recurrence (ASR) in
several studies (6–11). The recommended minimal ablation margin
is currently defined as 5 mm, a 10 mmmargin being preferred (1, 7,
9). At present, the ablation margin is most commonly assessed
visually, either using side-by-side juxtaposition of pre- and post-
ablation images or using image-fusion, and reported in 2D at the site
of largest tumor diameter (3, 4, 6, 12). The disadvantages of such
evaluation include an accuracy limited to one 2D image, which is
prone to subjectivity and inter-reader variability, even when
performed by experienced radiologists (13).
To address these issues, the evaluation of ablation margins in a
quantitative, volumetric manner has been proposed, including a
commercially available product (Ablation-fit™, R.A.W SRL,
Milano, Italy), applying (semi)- automatic segmentation of
tumor and ablation volumes and registration of pre- and post-
interventional images (12, 14–18). However, several important
challenges remain for application of these methods for assessment
of quantitative ablationmargins (QAM) on a broader scale. Firstly,
the description of circumferential ablation margins for tumors in
close vicinity to the liver capsule cannot be accomplished due to
the inherently limited surrounding liver parenchyma. These cases
are rarely addressed in the literature (12, 13), and no detailed
technical solution for the computation of QAM for subcapsular
tumors exists to date. Secondly, most studies focus on an average
minimal ablation margin, whereas the assessment of a quantitative
distribution of margin distances could take the accuracy of QAM
one step further. Thirdly, the lack of available codes or software
packages alongside the implementation descriptions currently
limits reproducibility of the described approaches.
The aim of this work was to introduce a method for increased
accuracy and standardized evaluation of ablation margins, for
future intra-operative feedback on the ablation completeness
during image-guided thermal ablation. To this end, a
quantitative volumetric approach for assessment of ablation
margins based on surface distance maps and an algorithm to2
address subcapsular tumors were developed. This work presents
the computational pipeline and experimental evaluation of the
QAM metric, using artificial examples and clinical data from
selected patients treated with stereotactic microwave ablation
(SMWA) for colorectal liver metastases (CRLM).MATERIAL AND METHODS
Development of Quantitative Ablation
Margin Metric
Requirements on Input Data
The requirements regarding input data to compute the QAM
metric included i) pre- and post-ablation scans co-registered and
resampled to the same space and size (image fusion). Ideally, this
is achieved during image acquisition by means of patient fixation
(e.g. vacuum mattress), reduction of breathing motion (e.g. jet
ventilation or controlled apnea) and image parameter selection,
factors which are typically achieved during stereotactic CT-
guided ablation procedures (2), ii) tumor and ablation volumes
segmented and saved as binary segmentation masks. For
subcapsular tumors, segmentation of the liver capsule
surrounding the liver tumor (at least 5 mm larger than the
tumor), iii) availability of all segmented masks with the same
dimensions in x, y, z directions and the same voxel spacing.
Computation Pipeline
Ablation margins are clinically defined as the area of necrosis
extending from the tumor surface to the ablation surface. The
proposed QAM method computes the distances from each
tumor surface voxel to the closest ablation surface voxel. To
this end, the exact Euclidean distance transform (19) was first
applied to the surface voxels of the ablation segmentation mask.
Distances were then extracted using the surface voxels of the
tumor segmentation mask. This method was based on the surface
Dice-Sørensen Coefficient, which measures the agreement
between two surfaces (20). The algorithm was adapted by
using a signed distance map to distinguish between positive
and negative margins, and an “exclusion volume” to exclude
tumor voxels near the liver surface in case of subcapsular tumors.
The QAM computation pipeline is illustrated in Figure 1.
More specifically, the calculations encompass the following
step-by-step algorithm:
1. Loading of input data (see Figure 1), consisting of
1.1. Tumor Segmentation
1.2. Ablation Segmentation
1.3. Liver Segmentation (exclusion volume for subcapsular
cases)March 2021 | Volume 11 | Article 623098
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input segmentations from Step 1 and cropping the volumes
to the smallest possible processing sub-volume (optional step
to decreases computation time without impacting the quality
of the results)
3. Computation of the contours of the cropped tumor, ablation,
and liver segmentations. Subtraction of a morphologically
eroded mask, using a structuring element with a three-by-one
shape to extract only face connected surface voxels (six-
connected). This ensures the contour being as “thin” as
possible (only one layer of voxels) and avoid exclusion of
corners where large edges are encountered in the segmentation.
4. Computation of the exact signed surface-to-surface Euclidean
distance on the ablation segmentation using the image
spacing. The exact Euclidean distance transform function
from SciPy (21) is employed to measure the closest distance
from each voxel to a voxel of the ablation mask contour, by
considering the voxel size of the image along each direction.
The distance is given by
yi =
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
oni xi − bið Þ2
q
,
where bi is the background value, xi is the foreground input
point and n is the number of dimensions.
5. Labeling of all background voxels (0/False) in the ablation
segmentation mask with −1 to create a signed distance map.
The latter is designed to define negative distances, i.e. tumor
voxels that are outside the ablation volume. Subsequent
voxel-wise multiplication of this ablation segmentation
mask with the distance map obtained at the previous step.Frontiers in Oncology | www.frontiersin.org 36. For subcapsular tumors: computation of the exact Euclidean
distance transform on the liver segmentation, setting all
tumor surface voxels which are closer than 5 mm to the
liver surface to 0 (see paragraph below).
7. Computation of the intersection between the tumor contour
voxels and the signed ablation distance map to extract the
tumor-to-ablation exact Euclidean surface distances.
The Special Case of Subcapsular Tumors
For subcapsular tumors, erroneously small ablation margins
might arise in quantitative ablation measurements, due to the
inherent impossibility of margins >5 mm if the tumor borders
with the liver capsule. To this end, a method to account for
potentially misleading negative or insufficient margins was
developed. Next to the tumor and ablation volume, the local
liver capsule surrounding the subcapsular tumor is segmented in
these cases. This is performed with a minimum of 5 mm
surrounding the tumor border, such that the tumor would not
be discarded in the QAM calculation. Subsequently, all tumor
voxels in less than 5 mm proximity to the liver capsule are
excluded from the computation by setting their value to 0/False
(background) (Figure 2). An exclusion volume threshold of
5 mm below the liver capsule was chosen following the most
frequently accepted definition of minimal margin for complete
ablation (6). However, this threshold could be modified
according to individual treatment targets.
Data Display and Visualization
The QAM output data are displayed i) numerically as the
maximum, minimum, and the 25th percentile, 50th percentileFIGURE 1 | Quantitative ablation margin (QAM) computation pipeline.March 2021 | Volume 11 | Article 623098
Sandu et al. Quantitative Ablation Margin (QAM)(median) and 75th percentile of calculated surface distances, and
ii) graphically as histograms displaying relative percentages of
ablation margin distances, i.e. tumor surface coverage in
substrata of 1 mm bins. The traffic light-colored histogram
with orange, yellow, and green represent ablation margins of
x < 0 mm, 0 ≥ x < 5 mm, and x ≥ 5mm, respectively. This range
was selected based on the current literature (6) but could be
modified according to clinical considerations. Additionally,
surface distances are projected onto the ablation volume
surface to visualize the areas of critical ablation margins in a
3D model, applying the same color scheme.
Code
NiBabel version 3.1.1 (https://nipy.org/nibabel/) was used to load
the input data passed as Neuroimaging Informatics Technology
Initiative (NiFTI) images to the main starting script, qam/main.py.
The Region-of-Interest (ROI) images were further converted into
arrays using NumPy version 1.19. To compute the surface
distances, the script qam/margin.py was called as a function.
Subsequently, the segmentation contours were extracted using
the morphological operation erosion with kernel size generated
by setting the structuring element as ndimage.generate_binary_
structure(3,1) from SciPy version 1.5.1. The exact surface-to-
surface Euclidean distances were computed with scipy.ndimage.
morphology.distance_transform_edt as implemented in SciPy
version 1.5.1. Histogram visualizations were displayed with
Seaborn version 0.10.1 (https://seaborn.pydata.org/) and Matplotlib
version 3.2.2. This code is located in the file qam/plotting.py. The
CT images shown in the Results section were visualized using
Mango version 4.1 (http://rii.uthscsa.edu/mango/). The 3D
visualizations were created using VTK version 9.0.1 (www.vtk.org).
This code is located in the file qam/visualization.py. An example
for automated QAM computation over a larger dataset is located
in the examples folder.
QAM Validation Experiments
Artificial Cases
To evaluate the accuracy and precision of the developed QAM
metric, a set of artificial input data was designed such that the
output data could be validated by comparisons with manual
calculation. These examples consist of spheres emulating tumors,
ablations, and liver capsules (Figure 3). All examples wereFrontiers in Oncology | www.frontiersin.org 4created programmatically and stored in the data format
described in section ‘Requirements on Input Data’. Two
representative cases were selected to illustrate QAM. Case T1.6
represents a 10 mm tumor which was ablated with a 15 mm
ablation zone shifted by 5 mm in x and y directions, leaving an
area of tumor with a negative margin. Case T2.2 represents a
subcapsular tumor with diameter of 10 mm and a 15 mm
ablation zone covering the entire tumor. This case was used to
assess the difference in QAM distribution with and without the
exclusion volume for subcapsular tumors.
Clinical Cases
To investigate applicability of the proposed QAM metric on
clinical ablation cases, a subset of representative patients treated
with stereotactic microwave ablation (SMWA) was selected
from a prospective database of a European multicenter cohort
trial (MAVERRIC, Microwave Ablation Versus Resection
for Resectable Colorectal Liver Metastases; clinicaltrials.gov:
NCT02642185) (22). In this trial, all tumors were treated using
stereotactic image-guidance systems (CAS-ONE IR, CAScination
AG, Bern, Switzerland and NPS, DEMCON Advanced
Mechatronics, Enschede, The Netherlands). Detailed set-up and
procedural workflows of both systems have previously been
described (2, 3, 23). To ensure minimal patient and liver
movement, all interventions were performed under general
anesthesia, using High Frequency Jet Ventilation (24) or
controlled apnoea and optionally with patients positioned on a
vacuum mattress. CT scans for qualitative ablation validation were
acquired immediately after the ablation treatment and with the
ablation probe withdrawn. Due to patient fixation and control of
breathing motion, the tumor (planning scan) and ablation
(ablation validation scan) CT scans were co-registered (image-
fusion). For segmentation of tumor and ablation volumes, and the
surrounding liver capsule in case of subcapsular tumors (defined
as a distance to the liver capsule of ≤5 mm), a semi-automatic
segmentation tool was used in Amira (Amira 6.3, ThermoFisher
Scientific, USA). Segmentation volumes were verified by
experienced radiologists from the respective clinical institutions.
Images from each tumor dataset were converted into the input
format described in Requirements on Input Data section,
resampled to the same size and voxel spacing as the final
validation CT scan and saved as NiFTI image format.FIGURE 2 | Schematic illustration of quantitative ablation margins (QAM) for subcapsular tumors. Left: Subcapsular tumor (red) surrounded by ablation volume
(blue). Center: Exclusion volume of 5 mm below liver capsule. Right: Remaining tumor surface used for final QAM computation.March 2021 | Volume 11 | Article 623098
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Code
The code for QAM is published as an open-source Python
(version 3.8.2) repository under https://github.com/artorg-
unibe-ch/qam. The code can be either integrated into existing
software packages or used as a stand-alone command line tool.
Additionally, the repository contains the code to generate the
artificial examples presented in the experimental section, in the
file “create_qam_test_cases.py”.
Artificial Cases
To assess the feasibility of the QAM metric, the QAM code was
run for all artificial examples and validated against manual
computations. The numerical results of all artificial cases can
be found in the supplementary material and the public code
repository. The results for the artificial case T1.6 are described
numerically and visually displayed below (Table 1, Figure 4). In
this example, the ablation sphere was shifted by 5 mm in both xFrontiers in Oncology | www.frontiersin.org 5and y directions, which lead to 27.93% of the tumor surface not
being covered (QAM x < 0 mm), 62.16% of the tumor surface
being covered with QAM 0 ≤ x < 5 mm and 9.91% of the tumor
surface being covered with a margin ≥ 5 mm.
To demonstrate how the algorithm for subcapsular tumors
influenced QAM distribution, the QAM results for case T2.2
with and without subtraction of a 5mm exclusion volume are
shown in Figure 5. The QAM 0 ≤ x < 5 mm changed from 98.2%
to 95.88%, and the QAM ≥ 5 mm from 1.80% to 4.12%, when a
5 mm subcapsular volume was subtracted.
Clinical Cases
The QAM code was run successfully for all clinical cases
extracted for margin analysis from the available study cohort
(n tumors = 65). Four representative cases were selected to assess
the applicability of using QAM for volumetric assessment of
ablation completeness in CRLM cases treated with SMWA.
While not explicitly measured, manual segmentation of
tumor and ablation volumes as well as the liver capsule, if
required, varied between 5 and 30 min depending on the
quality of contrast-enhancement of the CT scans. Using the
provided code, the time for QAM computation including
visualizations, depending on the lesion size, was generally
performed in under 30 s using a standard notebook. Figure 6
illustrates the volumetric QAM assessment of a patient treated
with SMWA for a CRLM lesion located in liver segment VI. In
this case, SMWA resulted in QAM ≥5 mm in 99.3% and QAM
0 ≥ x < 5 mm in 0.7%. The majority of tumor surface (24%) was
covered by an ablation margin of 8mm, with decreasing
frequencies of QAM > 8 mm to a maximum of 11 mm (3%),





Percentage of tumor surface covered at
distance
Min −2.23 x < 0 27.93%
25th percentile −1 x ≥ 0 < 5 62.16%
Median 1 x ≥ 5 9.91%
75th percentile 3
Max 7FIGURE 3 | Artificial examples simulating tumor (red) and ablation (blue) volumes. Left: non-subcapsular tumors and ablation volumes. Right: subcapsular tumors
with ablation volumes and their relationship to the liver capsule (green).March 2021 | Volume 11 | Article 623098
Sandu et al. Quantitative Ablation Margin (QAM)FIGURE 4 | Visualization of QAM histogram for non-subcapsular artificial case T1.6. Left: artificial example with tumor (red) shifted 5 mm in the x and y directions
with respect to the ablation (blue). Right: Histogram of relative distribution of margin distances displayed as 1 mm substrata.FIGURE 5 | Quantitative ablation margin (QAM) computation for subcapsular artificial case T2.2. with and without applying the algorithm for subcapsular tumors.
Left: T2.2 artificial example (tumor: red, ablation: blue, liver: green). Center: Relative distribution of margins with exclusion volume not subtracted in QAM
computation. Right: Relative distribution of margins with exclusion volume subtracted in QAM computation.FIGURE 6 | Volumetric assessment of quantitative ablation margins (QAM) in a patient treated with SMWA for a CRLM in liver segment VI. Left: Computed
tomogram image with segmented tumor (red) and ablation (blue) volumes. Center: Relative frequencies of ablation margin substrata with respect to percentage of
tumor surface covered. Right: 3D representation of the ablation margin projected onto the ablation surface.Frontiers in Oncology | www.frontiersin.org March 2021 | Volume 11 | Article 6230986
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a CRLM in segment VIII, located adjacent to a segment VIII
portal vein branch. In this example, the QAM metric resulted in
a tumor surface coverage rate ≥5 mm of 11.8% and 0 ≤ x < 5 mm
of 72.3%. A total tumor surface of 15.9% was ablated with
negative margins (QAM < 0 mm), of which 11.3% with −1 mm
and 4.6% with −2 mm. As visible from the CT image, the ablation
volume was of irregular, non-ellipsoid shape, with QAM ranging
from −1.8 mm to 6.8 mm, the main relative frequency of QAM
being 0 mm (28%). Table 2 shows a numerical presentation
of this clinical example, including minimal, maximal, and
interquartile range values.
The volumetric QAM assessment after SMWA for a CRLM
tumor located in a subcapsular position in segment V is
illustrated in Figure 8. In this example, a median QAM of
5.05 mm was reached, with an interquartile range from 3.35 to
6.56 mm. A QAM of 0 ≤ x < 5 mm 49.6% and QAM ≥ 5 mm of
50.4% were reached. Next to the distribution of relative QAM
frequencies, a visualization of the exact location of the QAMFrontiers in Oncology | www.frontiersin.org 7levels in 3D space is shown and displayed in the respective traffic-
light colors.
In Figure 9, an example case of a CRLM located in a
subcapsular position in liver segment VII is shown. To adjust
for the subcapsular lesion location, the surrounding liver capsule
was segmented and the computation of QAM adjusted asFIGURE 7 | Volumetric assessment of quantitative ablation margins (QAM) in a patient treated with SMWA for a CRLM in liver segment VIII. Left: Computed
tomogram image with segmented tumor (red) and ablation (blue) volumes. Center: Relative frequencies of ablation margin substrata with respect to percentage of
tumor surface covered. Right: 3D representation of the ablation margin projected onto the ablation surface, showing the area of negative margins in red.TABLE 2 | Numerical representation of the ablation margin of case presented in
Figure 7.
Case ID Figure 7
Euclidean distance
(mm)
Percentage of tumor surface covered at
distance
Min −1.8 x < 0 15.94%
25th percentile 0 x ≥ 0 < 5 72.29%
Median 1.8 x ≥ 5 11.78%
75th percentile 3.9
Max 6.8March 2021 | Volume 11 | ArticleFIGURE 8 | Volumetric assessment of quantitative ablation margins (QAM) of a subcapsular CRLM in liver segment V. Left: Computed tomogram with segmented
tumor (red), ablation (blue) volumes and the local liver capsule surrounding the tumor (green). Center: Relative frequencies of ablation margin substrata with respect
to percentage of tumor surface covered. Right: 3D representation of the ablation margin projected onto the ablation surface.623098
Sandu et al. Quantitative Ablation Margin (QAM)described. This tumor scored a QAM ≥ 5 mm of 39.7% and
QAM 0 ≤ x < 5 mm of 60.1%. To display the impact of the
proposed algorithm of QAM computation for subcapsular
tumors, the QAM histogram without adaption for subcapsular
tumors is additionally displayed. After applying the described
QAM computation for subcapsular tumors, the minimum QAM
changed from −1 to 3 mm, and the relative frequencies of QAM
substrata were re-distributed accordingly.DISCUSSION
This work proposes a method for quantifiable volumetric
assessment of ablation completeness after thermal ablation of
liver tumors. A computational pathway of quantitative ablation
margins (QAM) was developed using a signed Euclidean surface
distance map, including a novel algorithm to address subcapsularFrontiers in Oncology | www.frontiersin.org 8tumors. The computational code for applying the developed
QAMmetric was made publicly available, encouraging the use of
a standardized approach and definition in reporting ablation
margin coverage. Applicability of the proposed method was
shown in artificial and clinical examples, presenting a
numerical and visual way of displaying the QAM output.
The most important factor for treatment success after thermal
ablation of liver tumors is a complete tumor coverage by the
ablation volume (6, 12, 25). While nomenclature, time point, and
metric of the assessment of ablation completeness vary in the
current literature (26, 27), the necessity of an additional minimal
ablation margin encompassing the targeted tumor is generally
agreed upon (7, 9). The convention of defining a minimal
treatment margin stems from surgical resection, where the
histopathology result of the surgical specimen confidently
quantifies the surgical safety margin, allowing refined analyses
of subgroups of resection margins on tumor recurrence (28).
Contrarily, in image-guided thermal ablation the assessment ofMarch 2021 | Volume 11 | Article 623098FIGURE 9 | Volumetric assessment of quantitative ablation margins (QAM) of a subcapsular CRLM in liver segment VII. Upper left: Computed tomogram with
segmented tumor (red), ablation (blue) volumes and the local liver capsule surrounding the tumor (green). Upper right: 3D representation of the ablation margin
projected onto the ablation surface. Lower left: Histogram of ablation margin substrata without applying algorithm for subcapsular tumors. Lower right: Relative
frequencies of ablation margin substrata with respect to percentage of tumor surface covered when applying algorithm for subcapsular tumors.
Sandu et al. Quantitative Ablation Margin (QAM)treatment completeness is mainly performed by visual inspection
of follow-up imaging. Even though a correspondence between
radiologic and histopathologic findings in explanted livers was
reported after radiofrequency ablation of hepatocellular
carcinoma (29), a visual assessment without available
histopathology results remains subjective and prone to inter-
personal variations (13).
Toward a quantifiable result of treatment completeness after
thermal ablation—similar to a resection margin after surgical
resection—previous works have presented various approaches
for quantitative assessment of ablation margins, using either
surface-to-surface distances or volume overlaps. Hocquelet et al.
(16) previously described the ablation surface margin as the
distance between six connected background voxels to the
foreground voxels. Kaye et al. (12) presented a volumetric
approach by reporting the volume of insufficient tumor
coverage. Tani et al. (18) defined the concept of super-
imposing a Euclidean distance map over the 3D surface model
of the ablation similar to our methodology. A commercially
available software package (Ablation-fit™, R.A.W SRL, Milano,
Italy) for intra-procedural volumetric ablation assessment is
currently being investigated in clinical trials (15). As opposed
to these works, the strength of the herein presented QAM metric
is the public provision of the full code including a detailed
description of QAM substrata distributions, as well as the
introduction of an algorithm to address subcapsular tumors.
Although few attempts have been made to address this challenge
(12, 15), no systematic approach allowing robust replication has
been described so far. We confirmed that ablation margins can
be underestimated when applying the unadjusted QAM method
in subcapsular tumors (Figure 9), with the proposed algorithm
potentially leading to a more accurate measurement of the actual
ablation completeness according to a set definition. The QAM
method presented in this work was designed to be as
generalizable as possible, by avoiding dependencies to a
specific software platform for registration and segmentation,
and by being applicable to any thermal ablation treatment
(MWA, RFA) and CT-guided technique (conventional free-
hand, stereotactic navigation). However, since the accurate
registration of pre- and post-ablation imaging (image fusion) is
a pre-requisite of the technique, such software tools would ideally
be integrated into stereotactic image-guidance systems, where
they could provide immediate quantitative feedback on ablation
completeness and treatment success in a seamless workflow. The
use of (semi-) automatic segmentation algorithms would need to
be optimized and directly integrated into the navigation system’s
algorithm, potentially taking intra-procedural knowledge of
treatment completeness one step further. Similar to frozen
sections during surgery, this could allow immediate re-
treatment based on objective and quantitative feedback without
time delay, and therefore enhance treatment efficacy rates.
At its current stage, the application of this technique requires
not only an experienced radiologist but a technically oriented
member to pre-process (i.e. register, segment and store) the data
and run the computations. While this is applicable in highly
specialized centers or within clinical trials, only an integration ofFrontiers in Oncology | www.frontiersin.org 9these tools into software workflows will bring this technique to
widespread clinical use. Outside of navigation systems, the
technology would need to be integrated into dedicated
radiology software, or provided as a standalone software
package together with registration and segmentation tools.
This would facilitate the conduction of clinical trials
investigating optimal margin thresholds for different tumor
types and potentially ablation procedures in other organs (e.g.
lung, kidney).
Using QAM for accurate and reproducible assessment of
ablation completeness leads to several further important
aspects of local tumor control after thermal ablation of liver
tumors. Firstly, the QAM output will allow to objectively
differentiate between incomplete ablation and true ASR. In
light of the subjectivity of conventional visual inspection of
ablation completeness, ASR is currently defined as “the
appearance of tumor foci at the edge of the ablation zone after
at least one contrast-enhanced follow-up study has documented
adequate ablation and an absence of viable tissue in the target
tumor and surrounding ablation margin by using imaging
criteria” (27). QAM will not only allow avoiding time delays in
assessing ablation completeness, but enable the investigation of
factors influencing true ASR as opposed to remaining incomplete
ablation, arising on any follow-up imaging after initial ablation.
This would greatly help to standardize the reporting of outcomes
after thermal ablation of liver tumors. Secondly, QAM will allow
in-depth analyses of correlation between ablation margins and
ASR, toward the development of precision tools for prediction of
local tumor control. It will allow refined analyses using
distributions of margin substrata as opposed to a simple
“minimal ablation margin”, a correlation of QAM with regard
to ASR in 3D space, as well as interactions between QAM and
other factors known to affect ASR such as tumor diameter or
KRAS mutational status (25, 30). Without doubt, prospective
trials will be required to evaluate the predictive value of the QAM
metric with respect to ASR. Thirdly, QAM might serve as an
objective endpoint to study factors associated with the expansion
of ablation volumes, which remains to be poorly understood and
highly dependent on individual tumor- and patient-
related parameters.
A potential limitation of the proposed QAM algorithm to
assess ablation completeness in subcapsular tumors is a limited
applicability for very small tumors, e.g. <5 mm diameter, located
within 5 mm of the liver capsule. In this case, all tumor voxels
will be subtracted from the analysis, and no surface distances
yielded. If the QAM metric would be adapted regarding the
extent of subcapsular volume subtracted, a limited applicability
for the respective size of subcapsular tumors would need to be
kept in mind. Accordingly, a potential correlation between QAM
computation for subcapsular tumors and local tumor
progression would yield erroneous results if a recurrence
occurred in the subcapsular area, which would need to be
investigated in detail. While an alternative approach would
have been to consider the tumor surface proximal to the liver
capsule as completely ablated, we deliberately chose to subtract
this area as to not potentially report overestimated ablationMarch 2021 | Volume 11 | Article 623098
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typically produces wedge-shaped ablation volumes, supporting
the subcapsular exclusion threshold of 5 mm and a minimal
lateral ablation margin as a criterion of success in these cases. A
further application of such an exclusion volume from QAM
computation would be for tumors adjacent to major blood
vessels, where insufficient ablation margins might be reported
due to the heat sink effect. Another potential limitation arises due
to the fact that thermal ablation with MWA is known to cause
significant tissue shrinkage from desiccation and protein
denaturation immediately post treatment, with expansion of
ablation volumes thereafter (15, 31, 32). This might lead to an
underestimation of tumor coverage as assessed by QAM if
computed on the immediate post-interventional scan. Also,
even though the QAM metric was designed for use in all
approaches of percutaneous ablation, it might be more difficult
to apply if ablation is performed without stereotactic navigation,
in which case software for deformable registration would be
required (33). Since registration inaccuracies would lead to
imprecise estimation of QAM, verifying registration accuracy
before applying the QAM method is crucial. This said, image
fusion prior to QAM computation would ideally be evaluated
with an equally quantitative method to ensure accurate
registration of pre- and post-ablation images, regardless of the
type of targeting approach. It is of no doubt that the introduction
of novel technologies such as SMWA and QAM bring additional
efforts in the set-up and interventional workflows, the main
challenge representing an optimal training of staff, after which
learning curves are relatively fast and additional efforts can be
reduced (34). First comparative studies further suggest enhanced
treatment efficacy when using navigated ablation as opposed to
conventional targeting (35), hence, overall treatment costs might
be compensated if frequent re-treatments can be avoided. In
conclusion, this work presents and publicly displays an
algorithm for volumetric quantitative margin computation to
assess ablation completeness after thermal ablation of liver
tumors, including a novel algorithm to address subcapsular
tumors. The objectified feedback on ablation completeness
opens possibilities for intra-operative decision making and
refined analyses on predictability and consistency of local
tumor control after thermal ablation of liver tumors.Frontiers in Oncology | www.frontiersin.org 10DATA AVAILABILITY STATEMENT
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